Yasmeen Amber, Hosein Abdel N, Yu Qunyan, Al Moustafa Ala-Eddin
Program in Cancer Genetics, The Center for Experimental Therapeutics in Cancer, Lady Davis Institute for Medical Research of the Sir Mortimer B. Davis-Jewish General Hospital, McGill University Montreal, QC H3T1E2, Canada.
Cancer Sci. 2007 Jul;98(7):973-7. doi: 10.1111/j.1349-7006.2007.00504.x. Epub 2007 May 8.
Recently, we reported that E6/E7 of human papillomavirus (HPV) type 16 cooperates with the ErbB-2 receptor to induce cellular transformation of human normal oral epithelial (NOE) and mouse normal embryonic fibroblast (NEF) cells. Furthermore, we demonstrated that cyclin D1 is essential for this transformation induced by E6/E7 and E6/E7/ErbB-2 cooperation using cyclin D1 antisense and knockout (D1(-/-)) cells. To determine the role of all D-type cyclins (D1, D2 and D3) in E6/E7/ErbB-2 cooperation, we examined the effects of E6/E7, ErbB-2 alone and E6/E7/ErbB-2 together in NEF, NEF-D1(-/-), NEF-D2(-/-) and NEF-D3(-/-) cells. We confirm that NEF-E6/E7 and NEF-E6/E7/ErbB-2, but not NEF-ErbB-2 cells, induce colony formation in soft agar and tumor formation in nude mice. We report that E6/E7, ErbB-2 and E6/E7/ErbB-2 together all fail to induce neoplastic transformation of D1(-/-) and D2(-/-) cells in vitro and in vivo. In contrast, E6/E7/ErbB-2 together but neither E6/E7 nor ErbB-2 alone provoke cellular transformation of D3(-/-) cells. Nevertheless, D3(-/-)E6/E7/ErbB-2 cells resulted in up to a 60 and 50% decrease in colony and tumor formation in soft agar and nude mice, respectively, compared with NEF-E6/E7/ErbB-2 cells. Furthermore, using cyclin D2 small interfering RNA we inhibited tumor and colony formation of the human NOE-E6/E7-ErbB-2-transformed cell line; in contrast, cyclin D3 small interfering RNA repressed approximately 50% of colony and 40% of tumor formation of E6/E7/ErbB-2 cooperation in this cell line. These data suggest that cyclins D1, D2 and D3 (to a lesser extent) are important downstream mediators of the cellular transformation induced by E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Our data imply that anti-D-type cyclin therapies are important in the treatment of human cancers expressing high-risk HPV or HPV/ErbB-2.
最近,我们报道了人乳头瘤病毒16型(HPV-16)的E6/E7与ErbB-2受体协同作用,可诱导人正常口腔上皮(NOE)细胞和小鼠正常胚胎成纤维细胞(NEF)发生细胞转化。此外,我们还证明,使用细胞周期蛋白D1反义核酸和基因敲除(D1(-/-))细胞时,细胞周期蛋白D1对于由E6/E7以及E6/E7/ErbB-2协同作用所诱导的这种转化至关重要。为了确定所有D型细胞周期蛋白(D1、D2和D3)在E6/E7/ErbB-2协同作用中的作用,我们检测了E6/E7、单独的ErbB-2以及E6/E7/ErbB-2共同作用于NEF、NEF-D1(-/-)、NEF-D2(-/-)和NEF-D3(-/-)细胞后的效果。我们证实,NEF-E6/E7和NEF-E6/E7/ErbB-2细胞(而非NEF-ErbB-2细胞)可在软琼脂中诱导集落形成,并在裸鼠体内诱导肿瘤形成。我们报告称,E6/E7、ErbB-2以及E6/E7/ErbB-2共同作用均无法在体外和体内诱导D1(-/-)和D2(-/-)细胞发生肿瘤转化。相反,E6/E7/ErbB-2共同作用可诱导D3(-/-)细胞发生细胞转化,而单独的E6/E7或ErbB-2则不能。然而,与NEF-E6/E7/ErbB-2细胞相比,D(-/-)E6/E7/ErbB-2细胞在软琼脂中的集落形成以及在裸鼠体内的肿瘤形成分别减少了60%和最多50%。此外,我们使用细胞周期蛋白D2小干扰RNA抑制了人NOE-E6/E7-ErbB-2转化细胞系的肿瘤形成和集落形成;相反,细胞周期蛋白D3小干扰RNA抑制了该细胞系中E6/E7/ErbB-2协同作用所导致的约50%的集落形成和40%的肿瘤形成。这些数据表明,细胞周期蛋白D1、D2以及(程度较轻的)D3是正常细胞中由E6/E7以及E6/E7/ErbB-2协同作用所诱导的细胞转化的重要下游介质。我们的数据表明,抗D型细胞周期蛋白疗法对于治疗表达高危HPV或HPV/ErbB-2的人类癌症具有重要意义。